title: Clinical symptoms and risk factors in cerebral microangiopathy patients.
abstract: OBJECTIVE
  Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated retrospectively in a cohort of CM patients.
  
  
  METHODS
  Patients treated at the Department of Neurology, University of Bonn for CM (n = 223; 98m, 125f; aged 77.32±9.09) from 2005 to 2010 were retrospectively enrolled. Clinical symptoms, blood chemistry, potential risk factors, demographic data and ratings of vascular pathology in the brain based on the Wahlund scale were analyzed using Pearson's chi square test and one-way ANOVA.
  
  
  RESULTS
  Progressive cognitive decline (38.1%), gait apraxia (27.8%), stroke-related symptoms and seizures (24.2%), TIA-symptoms (22%) and vertigo (17%) were frequent symptoms within the study population. Frontal lobe WMLs/lacunar infarcts led to more frequent presentation of progressive cognitive decline, seizures, gait apraxia, stroke-related symptoms, TIA, vertigo and incontinence. Parietooccipital WMLs/lacunar infarcts were related to higher frequencies of TIA, seizures and incontinence. Basal ganglia WMLs/lacunar infarcts were seen in patients with more complaints of gait apraxia, vertigo and incontinence. Age (p = .012), arterial hypertension (p<.000), obesity (p<.000) and cerebral macroangiopathy (p = .018) were positively related to cerebral lesion load. For increased glucose level, homocysteine, CRP and D-Dimers there was no association.
  
  
  CONCLUSIONS
  This underlines the association of CM with neurological symptoms upon admission in a topographical manner. Seizures and vertigo are symptoms of CM which may have been missed in previous studies. In addition to confirming known risk factors such as aging and arterial hypertension, obesity appears to increase the risk as well. Since the incidence of CM is increasing, future studies should focus on the importance of prevention of vascular risk factors on its pathogenesis.
authors: Department of Neurology, Clinical Neuroscience Unit, University of Bonn, Bonn, Germany.
authors: Sandra
authors: S
authors: Okroglic
authors: Catherine N
authors: CN
authors: Widmann
authors: Horst
authors: H
authors: Urbach
authors: Philip
authors: P
authors: Scheltens
authors: Michael T
authors: MT
authors: Heneka
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology; D059345:Cerebral Small Vessel Diseases / Q000175:diagnosis* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D008297:Male; D009765:Obesity / Q000503:physiopathology; D012189:Retrospective Studies; D012307:Risk Factors
references: Circulation. 2005 Aug 9;112(6):900-5
references: 16061741
references: Arch Neurol. 1987 Jan;44(1):42-7
references: 3800721
references: FASEB J. 2011 Jan;25(1):5-13
references: 21205781
references: J Neurol Sci. 2007 Dec 15;263(1-2):75-8
references: 17610904
references: J Gerontol A Biol Sci Med Sci. 2004 Aug;59(8):818-26
references: 15345732
references: Int J Stroke. 2011 Feb;6(1):47-59
references: 21205241
references: Eur Neurol. 2007;57(2):70-4
references: 17179707
references: Psychol Med. 2010 Apr;40(4):603-10
references: 19671212
references: Neurology. 1998 May;50(5):1301-6
references: 9595978
references: Arch Neurol. 2005 Oct;62(10):1545-8
references: 16216937
references: Lancet Neurol. 2010 Jul;9(7):689-701
references: 20610345
references: J Clin Neurosci. 2007 Jan;14(1):17-21
references: 17138065
references: Acta Neurol Belg. 2004 Mar;104(1):13-9
references: 15143957
references: Neurology. 2008 Mar 18;70(12):935-42
references: 18347315
references: J Neurol Sci. 1995 Jun;130(2):171-7
references: 8586982
references: Cerebrovasc Dis. 2010;29(1):82-6
references: 19907168
references: Circulation. 2005 Sep 13;112(11):1644-50
references: 16145004
references: J Neurol. 2008 Mar;255(3):360-6
references: 18338199
references: Neurology. 1994 Jul;44(7):1246-52
references: 8035924
references: J Neurol Sci. 2007 Jun 15;257(1-2):166-73
references: 17350043
references: J Neurol Sci. 2009 Oct 15;285(1-2):185-90
references: 19619884
references: Stroke. 2001 Jun;32(6):1318-22
references: 11387493
references: J Am Geriatr Soc. 2008 Sep;56(9):1638-43
references: 18691285
references: J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):126-35
references: 20935330
references: Neurobiol Aging. 2010 Nov;31(11):2020-2
references: 19019492
references: Diabet Med. 1999 Feb;16(2):93-112
references: 10229302
references: J Neurol Sci. 2010 Jun 15;293(1-2):97-101
references: 20356606
references: Stroke. 2010 Mar;41(3):437-42
references: 20133919
references: Stroke. 2007 Aug;38(8):2356-9
references: 17600233
references: Ann Neurol. 2002 Mar;51(3):285-9
references: 11891822
references: Neurologist. 2008 Nov;14(6):355-64
references: 19008741
references: Ann N Y Acad Sci. 1997 Sep 26;826:92-102
references: 9329683
references: J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):608-13
references: 19204027
references: J Neurol. 2009 May;256(5):750-7
references: 19252811